Delivery Order SPE2DB20D1050-SPE2DB23FH93E
Award Date 8/23/23
Potential Completion Date 8/24/23
Potential Value $541
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,813 delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 200 mg XCOPRI medication. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD components. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on September 19, 2023. The firm fixed price order was awarded competitively...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $2,435 to Amerisourcebergen Drug Corporation to supply 50mg tablets of XCOPRI. The delivery order was issued against an existing DLA contract vehicle to provide pharmaceutical products and services to the Department of Defense. Amerisourcebergen will deliver 30 tablets of XCOPRI to a facility in Conshohocken, Pennsylvania by August 28, 2023 to fulfill requirements under this order. No subcontractors or...
- The Defense Logistics Agency awarded a $2,869.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg XCOPRI tablets. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located at the same address. The delivery order was issued on July 12, 2023 under the DLA's Pharmaceutical Prime Vendor contract to provide pharmaceuticals and medical supplies in support of...
- The Defense Logistics Agency awarded a $3,419.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50 mg XCOPRI tablets. Under this single award, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by June 27, 2023 to fulfill the Defense Logistics Agency's requirements. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen supports the DLA's logistics operations to ensure critical medications reach...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,001.25 to AmerisourceBergen Drug Corp for the supply of XCOPRI 50 MG tablets (30-count units) on October 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.46 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,165 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 50 mg tablets of XCOPRI to the agency. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 7 to 8, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery vehicle such as prime vendor arrangements to streamline...
- The Defense Logistics Agency awarded a $705.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the pharmaceutical product XCOPRI 50 MG. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 14, 2023 in support of the Defense Logistics Agency's medical supply needs. No set aside provisions or subcontractors are indicated. The Defense Logistics Agency manages the global supply chain for the United States military and...
- The Defense Logistics Agency awarded a $2,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg tablets of XCOPRI. The prime contractor will deliver 30 tablets to a location in Conshohocken, Pennsylvania, with performance required between August 1-2, 2023. Amerisourcebergen Corporation is the parent company for this order placed against an existing DLA contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this...
- The Defense Logistics Agency awarded a $1,712.07 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of XCOPRI 25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected through competitive...
Teaming
Find teaming partners for this award
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB23FH93EDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $541 to Amerisourcebergen Drug Corporation to supply 30 tablets of the 100mg XCOPRI medication. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 23rd to August 24th, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical medicines and materiel to the military through its prime vendor program. No set aside provisions or subcontractors were identified in the award provided.
Generated 12/15/23, 4:59 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $541 | 8/23/23 |